Publications by authors named "A Balint"
Background: Nursing home (NH) residents are frequently treated with antibiotics for urinary tract infections (UTIs), often due to overdiagnosis. The aim of this study was to evaluate the proportion of potentially unnecessary antibiotic use for suspected UTIs in NHs across eight European countries.
Research Design And Methods: Over a three-month period (February to April 2024), NH professionals recorded information on all antibiotic treatments for UTIs using a specific registration chart.
: Data on the real-world effectiveness and safety of selective JAK inhibitors (JAKis) in ulcerative colitis (UC) and Crohn's disease (CD) are limited. : We conducted a multicentre, retrospective study to assess clinical, biochemical, and endoscopic outcomes of selective JAKis in bio-experienced UC and CD. : A total of 246 patients (mean age: 40.
View Article and Find Full Text PDFObjectives: Understanding brain processing of auditory and visual speech is essential for advancing speech perception research and improving clinical interventions for individuals with hearing impairment. Functional near-infrared spectroscopy (fNIRS) is deemed to be highly suitable for measuring brain activity during language tasks. However, accurate data interpretation also requires validated stimuli and behavioral measures.
View Article and Find Full Text PDFBackground: Perianal fistulas of Crohn's disease (CD) create a significant burden on patients' lives. However, the efficacy and safety of adipose-derived mesenchymal stem cell treatment are contradicting, and real-world evidence is lacking.
Aims: To examine the usability of darvadstrocel therapy in managing perianal CD.
Article Synopsis
- The study investigates the effectiveness, safety, and patient preferences associated with switching from intravenous to subcutaneous vedolizumab treatment for inflammatory bowel diseases over a 52-week period.
- A total of 70 patients were included, with high rates of clinical and biochemical remission observed in both ulcerative colitis and Crohn's disease groups, while 17.1% discontinued the treatment primarily due to loss of response.
- Overall, switching to subcutaneous administration showed effective treatment persistence, stable remission rates, and no new safety concerns.